212 related articles for article (PubMed ID: 37477734)
1. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.
Huang D; Kidd JM; Zou Y; Wu X; Gehr TWB; Li PL; Li G
Inflammation; 2023 Oct; 46(5):2037-2054. PubMed ID: 37477734
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
[TBL] [Abstract][Full Text] [Related]
3. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia.
Huang D; Li G; Zhang Q; Bhat OM; Zou Y; Ritter JK; Li PL
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166146. PubMed ID: 33862145
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Acid Sphingomyelinase Promotes NLRP3 Inflammasome and Neointima Formation During Hypercholesterolemia.
Yuan X; Bhat OM; Zou Y; Li X; Zhang Y; Li PL
J Lipid Res; 2022 Dec; 63(12):100298. PubMed ID: 36252682
[TBL] [Abstract][Full Text] [Related]
5. Exosome Biogenesis and Lysosome Function Determine Podocyte Exosome Release and Glomerular Inflammatory Response during Hyperhomocysteinemia.
Huang D; Li G; Bhat OM; Zou Y; Li N; Ritter JK; Li PL
Am J Pathol; 2022 Jan; 192(1):43-55. PubMed ID: 34717894
[TBL] [Abstract][Full Text] [Related]
6. Abnormal podocyte TRPML1 channel activity and exosome release in mice with podocyte-specific Asah1 gene deletion.
Li G; Huang D; Bhat OM; Poklis JL; Zhang A; Zou Y; Kidd J; Gehr TWB; Li PL
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158856. PubMed ID: 33221496
[TBL] [Abstract][Full Text] [Related]
7. Regulation of TRPML1 channel activity and inflammatory exosome release by endogenously produced reactive oxygen species in mouse podocytes.
Li G; Huang D; Li N; Ritter JK; Li PL
Redox Biol; 2021 Jul; 43():102013. PubMed ID: 34030116
[TBL] [Abstract][Full Text] [Related]
8. Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene.
Boini KM; Xia M; Koka S; Gehr TW; Li PL
Oncotarget; 2016 Apr; 7(14):19031-44. PubMed ID: 26980705
[TBL] [Abstract][Full Text] [Related]
9. Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin.
Koka S; Xia M; Zhang C; Zhang Y; Li PL; Boini KM
Cell Physiol Biochem; 2019; 53(2):355-365. PubMed ID: 31385664
[TBL] [Abstract][Full Text] [Related]
10. Endothelial acid ceramidase in exosome-mediated release of NLRP3 inflammasome products during hyperglycemia: Evidence from endothelium-specific deletion of Asah1 gene.
Yuan X; Bhat OM; Lohner H; Zhang Y; Li PL
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158532. PubMed ID: 31647995
[TBL] [Abstract][Full Text] [Related]
11. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
Zhang Q; Conley SM; Li G; Yuan X; Li PL
Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal regulation of extracellular vesicle excretion during d-ribose-induced NLRP3 inflammasome activation in podocytes.
Hong J; Bhat OM; Li G; Dempsey SK; Zhang Q; Ritter JK; Li W; Li PL
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):849-860. PubMed ID: 30771382
[TBL] [Abstract][Full Text] [Related]
13. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
[TBL] [Abstract][Full Text] [Related]
14. Contribution of membrane raft redox signalling to visfatin-induced inflammasome activation and podocyte injury.
Koka S; Surineni S; Singh GB; Boini KM
Aging (Albany NY); 2023 Nov; 15(22):12738-12748. PubMed ID: 38032896
[TBL] [Abstract][Full Text] [Related]
15. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
[TBL] [Abstract][Full Text] [Related]
16. CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.
Zhao J; Rui HL; Yang M; Sun LJ; Dong HR; Cheng H
Mediators Inflamm; 2019; 2019():3172647. PubMed ID: 31097920
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
[TBL] [Abstract][Full Text] [Related]
18. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
[TBL] [Abstract][Full Text] [Related]
20. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
